Allergan (AGN) Tops Q4 EPS by 65c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Allergen (AGN) PT Raised to $203 at RBC Capital
February 10, 2020 11:45 AM ESTRBC Capital analyst Randall Stanicky raised the price target on Allergen (NYSE: AGN) to $203.00 (from $197.00) while maintaining a Sector Perform rating.
Strong 4Q results provide encouraging read- through to ABBV/AGN proforma outlook... More